David F Erkoboni

Title: David F Erkoboni: Innovator in Abuse Resistant Oral Dosage Forms

Introduction:

In the world of pharmaceutical innovation, individuals like David F Erkoboni play a vital role in developing breakthrough solutions that address critical healthcare challenges. With a location in Pennington, NJ (US), and an impressive track record, Erkoboni has made significant contributions concerning abuse-resistant oral dosage forms. This article will explore Erkoboni's latest patents, career highlights, notable collaborations, and highlight his achievements in the field.

Latest Patents:

David F Erkoboni has accumulated a total of 12 patents throughout his career. His most recent patents revolve around abuse-resistant oral dosage forms, particularly those incorporating compressed microtablets coated with a water-retardant polymer. These advancements seek to address concerns surrounding the misuse and abuse of opioid agonists.

Career Highlights:

Erkoboni has made remarkable contributions through his work with various esteemed organizations. Notably, he has served in significant roles at FMC Corporation and R.P. Scherer Technologies, Inc. (later acquired by Catalent Pharma Solutions). His expertise in developing abuse-resistant formulations has garnered recognition within the pharmaceutical industry.

Collaborations:

Throughout his career, David F Erkoboni has collaborated with accomplished professionals, further strengthening his position as an innovator. Noteworthy colleagues include Ronald S Vladyka and Pamela R Stergios, who have contributed to the research and development process alongside Erkoboni.

Conclusion:

With a passion for addressing the challenges surrounding abuse-resistant oral dosage forms, David F Erkoboni has made a tremendous impact on the pharmaceutical industry. His series of patents, particularly relating to compressed microtablets coated with water-retardant polymers, demonstrate his commitment to improving patient safety and combating opioid abuse. Erkoboni's collaborations and experiences within esteemed companies underline his ability to drive innovation through collaboration. As the field continues to evolve, it is individuals like David F Erkoboni who pave the way for safer and more effective pharmaceutical solutions.

Disclaimer: The information provided in this article is based on available data from public sources. For any specific details or inquiries regarding David F Erkoboni's work, kindly refer to official publications or contact authorized representatives.